|
TRDA Entrada Therapeutics Inc 1689375 |
| Balance Sheet |
|
Current Assets
|
$266,872,000.00 |
|
Assets
|
$335,518,000.00 |
|
Current Liabilities
|
$19,195,000.00 |
|
Liabilities
|
$64,664,000.00 |
|
Equity
|
$270,854,000.00 |
|
Shares Out
|
38820616.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-41,695,000.00 |
|
Investing Cash Flow
|
$26,987,000.00 |
| Market Analysis |
Market Cap
|
$262,815,570.32 |
|
Price
|
$6.82 |
|
BVPS
|
6.98 |
|
PB
|
0.97 |
|
EPS
|
-0.95 |
|
PS
|
85.63 |
|
FCF
|
$-41,739,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:33 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:30 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-26 |
-0.94 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
-0.95 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-06 |
-1.04 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
-1.06 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view TRDA documents filed with the SEC.
TRDA Filings
Clear
